KalVista Pharmaceuticals logo
KalVista Pharmaceuticals KALV
$ 8.47 4.7%

Quarterly report 2024-Q3
added 12-05-2024

report update icon

KalVista Pharmaceuticals Total Shareholders Equity 2011-2024 | KALV

Annual Total Shareholders Equity KalVista Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
257 M 83.8 M 96.7 M 27.3 M 31.3 M -37.1 M 49.3 M - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
257 M -37.1 M 72.6 M

Quarterly Total Shareholders Equity KalVista Pharmaceuticals

2024-Q3 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
134 M 207 M 88.6 M 114 M 139 M 161 M 184 M 144 M 165 M 185 M 58.6 M 227 M 244 M 244 M 89.7 M 65 M 65 M 74.4 M 104 M 97.8 M 97.8 M 102 M 28.6 M 107 M 107 M 26.2 M 34.8 M 31.1 M 31.1 M 26.7 M - 33.9 M 36 M 43.1 M 49.3 M 54.6 M 49.3 M 49.3 M -44.2 M -44.2 M -44.2 M -44.2 M -33.7 M - - - -28.3 M - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
244 M -44.2 M 80.5 M